Regenxbio (RGNX) Misses Q1 EPS by 38c, Misses on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.81 +0.18 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.63 | 52 Week High | $25.00 | |||
| Open | $7.72 | 52 Week Low | $7.07 | |||
| Day High | $7.96 | P/E | N/A | |||
| Day Low | $7.72 | EPS | $0.00 | |||
| Volume | 51,538 | |||||
